Your asking the wrong person. Maybe contact the company?
The market is more interested in unfounded medical claims and focusing more on supply of the product more than a registered pharmaceutical drug for pain management in replacement of opioid drugs.
- Forums
- ASX - By Stock
- MDC
- Ann: Medlab Progresses Nasdaq Dual Listing
Ann: Medlab Progresses Nasdaq Dual Listing, page-17
Featured News
Add MDC (ASX) to my watchlist
(20min delay)
|
|||||
Last
$6.60 |
Change
0.000(0.00%) |
Mkt cap ! $15.07M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
MDC (ASX) Chart |
Day chart unavailable